Aspercreme with Lidocaine
- Product NDC
- 41167-0584
- 11-digit product format
- 411670584
- Labeler code
- 41167
- Product ID
- 41167-0584_876c5973-157e-456d-bf0e-dfcd885efa0a
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Lidocaine
- Dosage form
- PATCH
- Route
- TOPICAL
- Labeler
- Chattem, Inc.
- Application
- M017
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2016-02-01
- Substance
- LIDOCAINE
- Active strength
- 4 g/100g
- Pharmacologic classes
- Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Code | Status | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | I | Inactivated by FDA | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 41167-0584-0 | I | Inactivated by FDA | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | I | Inactivated by FDA | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 41167-0584-0 | I | Inactivated by FDA | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | I | Inactivated by FDA | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 41167-0584-0 | I | Inactivated by FDA | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | I | Inactivated by FDA | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 41167-0584-0 | I | Inactivated by FDA | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | I | Inactivated by FDA | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 41167-0584-0 | I | Inactivated by FDA | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | I | Inactivated by FDA | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 41167-0584-0 | I | Inactivated by FDA | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded product | product | I | Inactivated by FDA | 8af77b9d5b6f… | d9bbb34c5368… | |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded package | package | 41167-0584-0 | I | Inactivated by FDA | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded product | product | I | Inactivated by FDA | 834df4deac94… | adcc014656a3… | |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded package | package | 41167-0584-0 | I | Inactivated by FDA | 834df4deac94… | adcc014656a3… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded product | product | I | Inactivated by FDA | 1332a3947898… | d4bfe170f9cd… | |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 41167-0584-0 | I | Inactivated by FDA | 1332a3947898… | d4bfe170f9cd… |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded product | product | Y | Unknown FDA exclusion code: Y | e2bbac7714bc… | 27bdfed8d636… | |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded package | package | 41167-0584-0 | Y | Unknown FDA exclusion code: Y | e2bbac7714bc… | 27bdfed8d636… |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded product | product | I | Inactivated by FDA | 9bebd1f3094a… | 5416666fcb17… | |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded package | package | 41167-0584-0 | I | Inactivated by FDA | 9bebd1f3094a… | 5416666fcb17… |
| 2019-12-08 06:16 UTC · source 2019-12-05 | excluded product | product | Y | Unknown FDA exclusion code: Y | 110d247fa046… | a55b01930146… | |
| 2019-12-08 06:16 UTC · source 2019-12-05 | excluded package | package | 41167-0584-0 | Y | Unknown FDA exclusion code: Y | 110d247fa046… | a55b01930146… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Aspercreme with Lidocaine
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| LIDOCAINE | 4 g/100g |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 98PI200987 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1737778 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 7ad8efa9-7031-4cd0-be1d-6dee63091fd1 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 070fbed5-7088-434a-a7ce-f2a64d8d40ac | Product name | 2 | 20260107 |
| bee66ce1-adb7-9d3b-67d9-582e4c54e80f | Product name | 5 | 20250819 |
| 860a93dc-4863-49cc-b284-6bbe8191bc48 | Product name | 4 | 20250214 |
| eaba870a-6a9d-442e-8643-87b3f558a451 | Product name | 1 | 20250117 |
| 9b4cf230-fd05-41d5-98c6-5db9ecb27b86 | Product name | 1 | 20230117 |
| 7d755fa1-1087-4dcd-98f0-6d4bba479a57 | Product name | 3 | 20210602 |
| f52be47f-7aa7-46c0-b1fa-50c18dd50206 | Product name | 1 | 20201029 |
| aed701d5-9c75-dfaf-7154-cde46179faea | Product name | 9 | 20200313 |
| fa8b5901-e681-426f-82fe-54f6d81ec698 | Product name | 4 | 20180619 |
| 332d03e4-aa24-4b11-841a-02bf41081920 | Product name | 1 | 20171221 |
| c08ab52f-2fc8-4409-9d9f-ed8edc0bd070 | Product name | 1 | 20171221 |
| 68ed98f8-24c2-44a0-944a-6d36e82ce25a | Product name | 1 | 20141222 |
| 1cd42bc2-a430-c72b-636d-991b235fbf80 | Product name | 1 | 20140508 |
| 49fa150c-f0de-cce7-3d9c-993ed81c5698 | Product name | 1 | 20140508 |
| 4d7ae718-ed00-bae8-2abe-9eaec1eef7ff | Product name | 1 | 20140508 |
| 9137811f-f279-8640-5aeb-99fa2145d64d | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| Effective | Related label |
|---|---|
| 2025-02-25 | Aspercreme Lidocaine Patch |
| 2024-01-30 | Aspercreme Lidocaine Patch |
| 2020-08-21 | Aspercreme Lidocaine Patch |
| 2020-01-31 | Aspercreme Lidocaine Patch |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 41167-0584-0 | Aspercreme with Lidocaine | 5 in 1 CARTON | PATCH | 5 | 9 | |
| 41167-0584-0 | Aspercreme with Lidocaine | 0.246 g in 1 PATCH | PATCH | 0.246 | 9 | |
| 41167-0584-3 | Aspercreme with Lidocaine | 6 in 1 CARTON | PATCH | 6 | 9 | |
| 41167-0584-3 | Aspercreme with Lidocaine | 0.246 g in 1 PATCH | PATCH | 0.246 | 9 | |
| 41167-0584-7 | Aspercreme with Lidocaine | 1 in 1 POUCH | PATCH | 1 | 9 | |
| 41167-0584-7 | Aspercreme with Lidocaine | 0.246 g in 1 PATCH | PATCH | 0.246 | 9 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 41167-0584-0 | EA - Each | 41167-0584 | 1b6ab028-704a-40b3-a1d7-83fcdfa99da7 | 1 | 2021-08-05 |
| 41167-0584-3 | EA - Each | 41167-0584 | b8b38c54-d192-4670-a6a5-b1d9c2d69fbc | 1 | 2026-04-20 |
| 41167-0584-7 | EA - Each | 41167-0584 | a3a45b60-f795-4263-bb67-4049710c15a4 | 1 | 2025-03-04 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 41167-0584 | ASPERCREME WITH LIDOCAINE (LIDOCAINE) PATCH [CHATTEM, INC.] | 8 | Current NDC, Legacy NDC, 6 package rows | 20250227_7ad8efa9-7031-4cd0-be1d-6dee63091fd1.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CVS Medicated Heat | CAPSICUM EXTRACT | CVS Pharmacy | 81cd1019-93a6-311b-e053-2991aa0a7997 | 2025-10-28 | Warnings | M017 |
| Foster and Thrive | LIDOCAINE | STRATEGIC SOURCING SERVICES, LLC | f950b072-d978-b629-e053-6394a90abfaf | 2025-10-28 | Warnings | M017 |
| Calamine Plus Pramoxine HCl | CALAMINE PLUS SPRAY | Premier Brands of America, Inc. | d3452573-f91f-f157-e053-2a95a90a1ad8 | 2025-10-27 | Warnings | M017 |
| Medi-First Hydrocortisone 1% | HYDROCORTISONE ACETATE 1% | Unifirst First Aid Corporation | f2b46d69-1c21-5ae9-e053-2a95a90a60a9 | 2025-10-24 | Warnings | M017 |
| Extra Strength | MENTHOL AND METHYL SALICYLATE | Saje Natural Business Inc. | 87d872b3-3231-d0f2-e053-2995a90a9d98 | 2025-10-24 | Warnings | M017 |
| Signature Care Cold and Hot | MENTHOL, AND METHYL SALICYLATE | Safeway Inc. | ab201023-e3dc-52ec-e053-2995a90a1f18 | 2025-10-24 | Warnings | M017 |
| HealthWise Medicated Cold Hot 5% Patch | MENTHOL | Veridian Healthcare | 15aef56f-cd25-05ac-e063-6394a90a07bb | 2025-10-23 | Warnings | M017 |
| Alivio | LIDOCAINE | Amerise Pharmaceuticals LLC | eb3a98f1-c875-4f08-8b4b-44e22626b609 | 2025-10-23 | Warnings | M017 |
| Pain Relieveing Gel-Patch | LIDOCAINE | Bullet point LLC | 41d507c4-ad37-2686-e063-6394a90aae5b | 2025-10-23 | Warnings | M017 |
| ActivICE | MENTHOL | Medline Industries, LP | 98fa9a34-0e1e-0997-e053-2a95a90ac77d | 2025-10-23 | Warnings | M017 |
| Americaine | BENZOCAINE | Insight Pharmaceuticals LLC | 4fd14452-0285-40c4-b835-36935c2056b2 | 2025-10-23 | Warnings | M017 |
| zourunan PAIN RELIEF | PAIN RELIEF | Guchutang Biotechnology (Longyan) Co., Ltd | 41bc1c0c-63d5-0d41-e063-6394a90a341b | 2025-10-22 | Warnings | M017 |
| zourunan PAIN RELIEF | PAIN RELIEF | Guchutang Biotechnology (Longyan) Co., Ltd | 41bd0769-6ba0-d0d5-e063-6294a90af7c9 | 2025-10-22 | Warnings | M017 |
| Coralite Extra Strength Pain Relief Sleeve Knee | MENTHOL | United Exchange Corp. | aa5873bd-af64-41cc-8f16-7714c56bca96 | 2025-10-22 | Warnings | M017 |
| Family Care Muscle Rub | CAMPHOR, MENTHOL, AND METHYL SALICYLATE | United Exchange Corp. | 63006bb5-76e8-eb64-e053-2991aa0a95ad | 2025-10-22 | Warnings | M017 |
| Winco Cold and Hot Medicated Patch Large | MENTHOL | WINCO FOODS, LLC | af0d86c4-f74e-2dbe-e053-2a95a90a74c1 | 2025-10-22 | Warnings | M017 |
| Coralite Cold and Hot | MENTHOL | United Exchange Corp. | 064a6149-a0e2-8a73-e063-6394a90a7953 | 2025-10-22 | Warnings | M017 |
| Topical Analgesic | MENTHOL | Youngevity International Inc. | b4693947-f5b3-6fd3-e053-2995a90ab581 | 2025-10-22 | Warnings | M017 |
| PAIN RELIEVING | LIDOCAINE | Medhome Pharma Inc | 41cb1135-84e0-0c9a-e063-6294a90ada96 | 2025-10-22 | Warnings | M017 |
| KINKAN | AMMONIA, CAMPHOR (NATURAL), MENTHOL | KINKANDO CO., LTD . | f2c0f3e1-792b-4798-bf6d-acd1bbefa261 | 2025-10-21 | Warnings | M017 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1737778 | lidocaine 4 % Medicated Patch | PSN | 7ad8efa9-7031-4cd0-be1d-6dee63091fd1 | 9 |
| 1737778 | lidocaine 0.04 MG/MG Medicated Patch | SCD | 7ad8efa9-7031-4cd0-be1d-6dee63091fd1 | 9 |
| 1737778 | lidocaine 4 % Medicated Patch | SY | 7ad8efa9-7031-4cd0-be1d-6dee63091fd1 | 9 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 41167-0584-0 | 41167058400 | 5 PATCH in 1 CARTON (41167-0584-0) / .246 g in 1 PATCH | 5 patch | 2016-02-01 | 0000-00-00 | No | No | Current |
| 41167-0584-3 | 41167058403 | 6 PATCH in 1 CARTON (41167-0584-3) / .246 g in 1 PATCH | 6 patch | 2026-01-01 | No | No | Current | |
| 41167-0584-7 | 41167058407 | 1 PATCH in 1 POUCH (41167-0584-7) / .246 g in 1 PATCH | 1 patch | 2016-02-01 | No | No | Current |